{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:26:48Z","timestamp":1792189608236,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1F1A1072226"],"award-info":[{"award-number":["2020R1F1A1072226"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The purpose of this study was to analyze the correlation of renal function indices with sub-foveal choroidal thickness (SFChT) in treatment-na\u00efve (na\u00efve) eyes with retinal vein occlusion (RVO) using swept-source optical coherence tomography (SS-OCT) and systemic workup. Retrospective chart review was performed from Dec 2016 to Sep 2019 in patients newly diagnosed with treatment-na\u00efve unilateral RVO. Ocular parameters, including SFChT, and systemic profiles, including renal function indices, were reviewed. Simple and multiple linear regression analyses were performed to check if there was a correlation between renal profiles and SFChT. A total of 56 patients were included in the study; 34 of them were branch RVO and 22 were central RVO patients. Multiple linear regression analysis revealed that SFChT was positively correlated with estimated glomerular filtration rate (eGFR) (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). SFChT showed significant correlation with renal function indices. In addition, choroidal thickness may be considered as systemic biomarkers for renal function.<\/jats:p>","DOI":"10.1038\/s41598-020-74058-0","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T10:03:22Z","timestamp":1602151402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Correlations between choroidal thickness and renal function in patients with retinal vein occlusion"],"prefix":"10.1038","volume":"10","author":[{"given":"Sang Uk","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja Young","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee Taek","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"key":"74058_CR1","doi-asserted-by":"publisher","first-page":"010427","DOI":"10.7189\/jogh.09.010427","volume":"9","author":"P Song","year":"2019","unstructured":"Song, P., Xu, Y., Zha, M., Zhang, Y. & Rudan, I. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J. Glob. Health 9, 010427. https:\/\/doi.org\/10.7189\/jogh.09.010427 (2019).","journal-title":"J. Glob. Health"},{"key":"74058_CR2","doi-asserted-by":"publisher","first-page":"313 e311","DOI":"10.1016\/j.ophtha.2009.07.017","volume":"117","author":"S Rogers","year":"2010","unstructured":"Rogers, S. et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 117, 313 e311-319 e311. https:\/\/doi.org\/10.1016\/j.ophtha.2009.07.017 (2010).","journal-title":"Ophthalmology"},{"key":"74058_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000455278","volume":"58","author":"JB Jonas","year":"2017","unstructured":"Jonas, J. B., Mones, J., Glacet-Bernard, A. & Coscas, G. Retinal vein occlusions. Dev. Ophthalmol. 58, 139\u2013167. https:\/\/doi.org\/10.1159\/000455278 (2017).","journal-title":"Dev. Ophthalmol."},{"key":"74058_CR4","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1016\/j.ophtha.2009.05.041","volume":"116","author":"S Wang","year":"2009","unstructured":"Wang, S. et al. Major eye diseases and risk factors associated with systemic hypertension in an adult Chinese population: the Beijing Eye Study. Ophthalmology 116, 2373\u20132380. https:\/\/doi.org\/10.1016\/j.ophtha.2009.05.041 (2009).","journal-title":"Ophthalmology"},{"key":"74058_CR5","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ophtha.2004.10.039","volume":"112","author":"TY Wong","year":"2005","unstructured":"Wong, T. Y. et al. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health studies. Ophthalmology 112, 540\u2013547. https:\/\/doi.org\/10.1016\/j.ophtha.2004.10.039 (2005).","journal-title":"Ophthalmology"},{"key":"74058_CR6","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ophtha.2006.06.061","volume":"114","author":"S Cugati","year":"2007","unstructured":"Cugati, S. et al. Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts. Ophthalmology 114, 520\u2013524. https:\/\/doi.org\/10.1016\/j.ophtha.2006.06.061 (2007).","journal-title":"Ophthalmology"},{"key":"74058_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.atherosclerosis.2017.11.001","volume":"268","author":"G Mule","year":"2018","unstructured":"Mule, G., Vadala, M., Geraci, G. & Cottone, S. Retinal vascular imaging in cardiovascular medicine: new tools for an old examination. Atherosclerosis 268, 188\u2013190. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.11.001 (2018).","journal-title":"Atherosclerosis"},{"key":"74058_CR8","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1016\/j.ophtha.2013.08.031","volume":"120","author":"KF Du","year":"2013","unstructured":"Du, K. F. et al. Subfoveal choroidal thickness in retinal vein occlusion. Ophthalmology 120, 2749\u20132750. https:\/\/doi.org\/10.1016\/j.ophtha.2013.08.031 (2013).","journal-title":"Ophthalmology"},{"key":"74058_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12886-019-1143-9","volume":"19","author":"F Tang","year":"2019","unstructured":"Tang, F. et al. Comparison of subfoveal choroidal thickness in eyes with CRVO and BRVO. BMC Ophthalmol. 19, 133. https:\/\/doi.org\/10.1186\/s12886-019-1143-9 (2019).","journal-title":"BMC Ophthalmol."},{"key":"74058_CR10","doi-asserted-by":"publisher","first-page":"e89173","DOI":"10.1172\/jci.insight.89173","volume":"1","author":"C Balmforth","year":"2016","unstructured":"Balmforth, C. et al. Chorioretinal thinning in chronic kidney disease links to inflammation and endothelial dysfunction. JCI Insight 1, e89173. https:\/\/doi.org\/10.1172\/jci.insight.89173 (2016).","journal-title":"JCI Insight"},{"key":"74058_CR11","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s00417-019-04358-3","volume":"257","author":"M Vadala","year":"2019","unstructured":"Vadala, M. et al. Retinal and choroidal vasculature changes associated with chronic kidney disease. Graefes Arch. Clin. Exp. Ophthalmol. 257, 1687\u20131698. https:\/\/doi.org\/10.1007\/s00417-019-04358-3 (2019).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"74058_CR12","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/s41440-018-0195-1","volume":"42","author":"G Mule","year":"2019","unstructured":"Mule, G. et al. Association between early-stage chronic kidney disease and reduced choroidal thickness in essential hypertensive patients. Hypertens. Res. 42, 990\u20131000. https:\/\/doi.org\/10.1038\/s41440-018-0195-1 (2019).","journal-title":"Hypertens. Res."},{"key":"74058_CR13","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1097\/01.asn.0000095249.99803.85","volume":"14","author":"MK Haroun","year":"2003","unstructured":"Haroun, M. K. et al. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J. Am. Soc. Nephrol. 14, 2934\u20132941. https:\/\/doi.org\/10.1097\/01.asn.0000095249.99803.85 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"74058_CR14","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/ki.2013.491","volume":"85","author":"CW Wong","year":"2014","unstructured":"Wong, C. W., Wong, T. Y., Cheng, C. Y. & Sabanayagam, C. Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways. Kidney Int. 85, 1290\u20131302. https:\/\/doi.org\/10.1038\/ki.2013.491 (2014).","journal-title":"Kidney Int."},{"key":"74058_CR15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ophtha.2012.09.033","volume":"120","author":"JQ Zhou","year":"2013","unstructured":"Zhou, J. Q. et al. The 10-year incidence and risk factors of retinal vein occlusion: the Beijing eye study. Ophthalmology 120, 803\u2013808. https:\/\/doi.org\/10.1016\/j.ophtha.2012.09.033 (2013).","journal-title":"Ophthalmology"},{"key":"74058_CR16","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1001\/archopht.124.5.726","volume":"124","author":"S Cugati","year":"2006","unstructured":"Cugati, S., Wang, J. J., Rochtchina, E. & Mitchell, P. Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. Arch. Ophthalmol. 124, 726\u2013732. https:\/\/doi.org\/10.1001\/archopht.124.5.726 (2006).","journal-title":"Arch. Ophthalmol."},{"key":"74058_CR17","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/jth.12982","volume":"13","author":"KA Ponto","year":"2015","unstructured":"Ponto, K. A. et al. Prevalence and risk factors of retinal vein occlusion: the Gutenberg Health Study. J. Thromb. Haemost. 13, 1254\u20131263. https:\/\/doi.org\/10.1111\/jth.12982 (2015).","journal-title":"J. Thromb. Haemost."},{"key":"74058_CR18","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nrd.2016.67","volume":"15","author":"MD Breyer","year":"2016","unstructured":"Breyer, M. D. & Susztak, K. The next generation of therapeutics for chronic kidney disease. Nat. Rev. Drug. Discov. 15, 568\u2013588. https:\/\/doi.org\/10.1038\/nrd.2016.67 (2016).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"74058_CR19","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/01.asn.0000051705.97966.ad","volume":"14","author":"H Izzedine","year":"2003","unstructured":"Izzedine, H., Bodaghi, B., Launay-Vacher, V. & Deray, G. Eye and kidney: from clinical findings to genetic explanations. J. Am. Soc. Nephrol. 14, 516\u2013529. https:\/\/doi.org\/10.1097\/01.asn.0000051705.97966.ad (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"74058_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.molimm.2005.06.015","volume":"43","author":"PF Zipfel","year":"2006","unstructured":"Zipfel, P. F., Heinen, S., Jozsi, M. & Skerka, C. Complement and diseases: defective alternative pathway control results in kidney and eye diseases. Mol. Immunol. 43, 97\u2013106. https:\/\/doi.org\/10.1016\/j.molimm.2005.06.015 (2006).","journal-title":"Mol. Immunol."},{"key":"74058_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.peptides.2012.04.008","volume":"36","author":"JL Wilkinson-Berka","year":"2012","unstructured":"Wilkinson-Berka, J. L., Agrotis, A. & Deliyanti, D. The retinal renin-angiotensin system: roles of angiotensin II and aldosterone. Peptides 36, 142\u2013150. https:\/\/doi.org\/10.1016\/j.peptides.2012.04.008 (2012).","journal-title":"Peptides"},{"key":"74058_CR22","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/HYPERTENSIONAHA.111.189142","volume":"60","author":"CY Cheung","year":"2012","unstructured":"Cheung, C. Y., Ikram, M. K., Sabanayagam, C. & Wong, T. Y. Retinal microvasculature as a model to study the manifestations of hypertension. Hypertension 60, 1094\u20131103. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.189142 (2012).","journal-title":"Hypertension"},{"key":"74058_CR23","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1097\/01.ASN.0000136133.28194.E4","volume":"15","author":"TY Wong","year":"2004","unstructured":"Wong, T. Y. et al. Retinal microvascular abnormalities and renal dysfunction: the atherosclerosis risk in communities study. J. Am. Soc. Nephrol. 15, 2469\u20132476. https:\/\/doi.org\/10.1097\/01.ASN.0000136133.28194.E4 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"74058_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000437276","volume":"234","author":"KH Kim","year":"2015","unstructured":"Kim, K. H. et al. Regional choroidal thickness changes in branch retinal vein occlusion with macular edema. Ophthalmologica 234, 109\u2013118. https:\/\/doi.org\/10.1159\/000437276 (2015).","journal-title":"Ophthalmologica"},{"key":"74058_CR25","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/iae.0000000000001566","volume":"38","author":"M Okamoto","year":"2018","unstructured":"Okamoto, M., Yamashita, M., Sakamoto, T. & Ogata, N. Choroidal blood flow and thickness as predictors for response to anti-vascular endothelial growth factor therapy in macular edema secondary to branch retinal vein occlusion. Retina 38, 550\u2013558. https:\/\/doi.org\/10.1097\/iae.0000000000001566 (2018).","journal-title":"Retina"},{"key":"74058_CR26","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1097\/iae.0000000000001099","volume":"36","author":"E Esen","year":"2016","unstructured":"Esen, E., Sizmaz, S. & Demircan, N. Choroidal thickness changes after intravitreal dexamethasone implant injection for the treatment of macular edema due to retinal vein occlusion. Retina 36, 2297\u20132303. https:\/\/doi.org\/10.1097\/iae.0000000000001099 (2016).","journal-title":"Retina"},{"key":"74058_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.preteyeres.2017.12.001","volume":"64","author":"A Reiner","year":"2018","unstructured":"Reiner, A., Fitzgerald, M. E. C., Del Mar, N. & Li, C. Neural control of choroidal blood flow. Prog. Retin. Eye Res. 64, 96\u2013130. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.12.001 (2018).","journal-title":"Prog. Retin. Eye Res."},{"key":"74058_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ajo.2013.04.008","volume":"156","author":"E Tsuiki","year":"2013","unstructured":"Tsuiki, E., Suzuma, K., Ueki, R., Maekawa, Y. & Kitaoka, T. Enhanced depth imaging optical coherence tomography of the choroid in central retinal vein occlusion. Am. J. Ophthalmol. 156, 543-547.e541. https:\/\/doi.org\/10.1016\/j.ajo.2013.04.008 (2013).","journal-title":"Am. J. Ophthalmol."},{"key":"74058_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1136\/bjophthalmol-2018-311898","volume":"103","author":"N Rayess","year":"2019","unstructured":"Rayess, N. et al. Baseline choroidal thickness as a short-term predictor of visual acuity improvement following antivascular endothelial growth factor therapy in branch retinal vein occlusion. Br. J. Ophthalmol. 103, 55\u201359. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-311898 (2019).","journal-title":"Br. J. Ophthalmol."},{"key":"74058_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ajo.2016.08.026","volume":"171","author":"N Rayess","year":"2016","unstructured":"Rayess, N. et al. Baseline choroidal thickness as a predictor for treatment outcomes in central retinal vein occlusion. Am. J. Ophthalmol. 171, 47\u201352. https:\/\/doi.org\/10.1016\/j.ajo.2016.08.026 (2016).","journal-title":"Am. J. Ophthalmol."},{"key":"74058_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00417-019-04475-z","volume":"258","author":"JT Kim","year":"2020","unstructured":"Kim, J. T. & Park, N. Changes in choroidal vascular parameters following pan-retinal photocoagulation using swept-source optical coherence tomography. Graefes Arch. Clin. Exp. Ophthalmol. 258, 39\u201347. https:\/\/doi.org\/10.1007\/s00417-019-04475-z (2020).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74058-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74058-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74058-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T20:53:39Z","timestamp":1670360019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74058-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["74058"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-74058-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,8]]},"assertion":[{"value":"12 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16865"}}